(Q33769719)

29 July 2017

1 reference

title

Pathophysiology and treatment of graft-versus-host disease (English)

1 reference

29 July 2017

1 reference

Flowers ME

1

1 reference

PubMed ID

10553263

29 July 2017

Kansu E

series ordinal

2

1 reference

PubMed ID

10553263

29 July 2017

Sullivan KM

series ordinal

3

1 reference

29 July 2017

1 October 1999

1 reference

Hematology / Oncology Clinics of North America

29 July 2017

1 reference

29 July 2017

13

1 reference

29 July 2017

1091-112, viii-ix

1 reference

29 July 2017

5

1 reference

A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

The quality of life in adult survivors of allogeneic bone marrow transplantation. Correlates and comparison with matched renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Phototherapy in the treatment of cutaneous graft-versus-host disease. Our preliminary experience in resistant patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Marrow transplantation from related donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Chronic graft-versus-host disease in the rat radiation chimera. III. Immunology and immunopathology in rapidly induced models

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Pediatric lung transplantation for graft-versus-host disease following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Risk factors for airflow obstruction in recipients of bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Avascular necrosis following bone marrow transplantation: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Sjögren-Type Syndrome After Allogeneic Bone-Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Graft-versus-host reaction complicating HL-A matched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Graft versus host reactions following transplantation of allogeneic hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

How much benefit can be expected from matching for minor antigens in allogeneic marrow transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Treatment of acute graft-versus-host disease with anti-CD3 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

HAEMATOPOIETIC CHIMERA IN MAN AFTER ALLOGENIC (HOMOLOGOUS) BONE-MARROW TRANSPLANTATION. (CONTROL OF THE SECONDARY SYNDROME. SPECIFIC TOLERANCE DUE TO THE CHIMERISM).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

A randomized study of the prevention of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Immunomodulatory peptides with high binding affinity for class II MHC molecules for the prevention of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

The management of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Graft-versus-host-reactions: the history that never was, and the way things happened to happen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Low-dose (one gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Association between HLA-B antigens and acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970111-8

7 January 2021

10.1016/S0889-8588(05)70111-8

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10553263